Akanda’s CanMart Partners with Phlo Connect and Cellen Life Sciences to Dispense & Deliver High Quality Medical Cannabis Products in the UK
LONDON–(BUSINESS WIRE)– Akanda Corp. (“Akanda” or the “Company”) (NASDAQ: AKAN), an international medical cannabis platform company, today announced that its UK import and […]
Akanda Announces Changes to Board of Directors and Postponement of Annual General Meeting
TORONTO–(BUSINESS WIRE)– Akanda Corp. (“Akanda” or the “Company”) today announced certain changes to its board of directors (the “Board”) and the postponement of […]
Akanda Completes Acquisition of Holigen, Advancing Cannabis Leadership Position in Europe, the Middle East and Africa (EMEA)
Adds prized cultivation, manufacturing and distribution assets and an award-winning genetics library, accelerating Akanda’s seed-to-patient model LONDON–(BUSINESS WIRE)– International medical cannabis company Akanda […]
Akanda to Acquire Portugal-based Holigen, Securing a Cannabis Sector Leadership Position in Europe, the Middle East and Africa (EMEA) with EU GMP Market Access
Transformational deal will add prized cultivation, manufacturing and distribution assets to accelerate Akanda’s seed-to-patient model and satisfy demand in fast-growing European cannabis […]
Akanda Corp. Announces Pricing of Initial Public Offering
LONDON–(BUSINESS WIRE)–Akanda Corp. (“Akanda” or the “Company”), an international medical cannabis company, today announced the pricing of its initial public offering of […]
Akanda Corp. Closes Initial Public Offering
LONDON–(BUSINESS WIRE)– Akanda Corp. (“Akanda” or the “Company”), an international medical cannabis company, today announced the completion of its initial public offering of […]
Akanda Corp. Common Shares Set to Commence Trading Today on Nasdaq Under Ticker Symbol “AKAN”
LONDON–(BUSINESS WIRE)– Akanda Corp (NASDAQ: AKAN) (“Akanda” or the “Company”), an international medical cannabis company, today announced the Company’s common shares are scheduled […]
Akanda Corp. Closes Its First Day of Trading on The NASDAQ Capital Market
LONDON–(BUSINESS WIRE)– Akanda Corp. (NASDAQ: AKAN) (“Akanda” or the “Company”), an international medical cannabis company, today commenced the trading of its common shares […]
Akanda Corp. Names Dr. Sunny Nayee as U.K. Medical Director to Support Partnership with Cellen Life Sciences
Expert in Chronic Pain Management Joins International Medical Cannabis Company LONDON–(BUSINESS WIRE)–International medical cannabis company Akanda Corp. (“Akanda” or the “Company”) today […]
Akanda Corp. Names Gila Jones, Gugu Dingaan and Bridget Baker to Board of Directors
Dynamic Group of Accomplished Women Round Out Leadership Team LONDON–(BUSINESS WIRE)–Akanda Corp. (“Akanda” or the “Company”) today announced the appointment of Gila […]
Akanda Corp. Announces Confidential Submission of Draft Registration Statement for Proposed Initial Public Offering
LONDON–(BUSINESS WIRE)–International medical cannabis company Akanda Corp. (“Akanda” or the “Company”) today announced that it has submitted a confidential draft registration statement […]
Akanda Corp. Closes $5 Million Private Placement
LONDON–(BUSINESS WIRE)–Akanda Corp. (“Akanda” or the “Company”) today announced that it has closed a private placement for aggregate gross proceeds of $5,316,000. […]